1. Home
  2. COEP vs FENG Comparison

COEP vs FENG Comparison

Compare COEP & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • FENG
  • Stock Information
  • Founded
  • COEP 2017
  • FENG 1998
  • Country
  • COEP United States
  • FENG China
  • Employees
  • COEP N/A
  • FENG N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • FENG Broadcasting
  • Sector
  • COEP Health Care
  • FENG Industrials
  • Exchange
  • COEP Nasdaq
  • FENG Nasdaq
  • Market Cap
  • COEP 30.5M
  • FENG 29.7M
  • IPO Year
  • COEP N/A
  • FENG 2011
  • Fundamental
  • Price
  • COEP $9.48
  • FENG $2.25
  • Analyst Decision
  • COEP
  • FENG
  • Analyst Count
  • COEP 0
  • FENG 0
  • Target Price
  • COEP N/A
  • FENG N/A
  • AVG Volume (30 Days)
  • COEP 42.3K
  • FENG 6.3K
  • Earning Date
  • COEP 05-09-2025
  • FENG 03-11-2025
  • Dividend Yield
  • COEP N/A
  • FENG N/A
  • EPS Growth
  • COEP N/A
  • FENG N/A
  • EPS
  • COEP N/A
  • FENG N/A
  • Revenue
  • COEP N/A
  • FENG $96,408,461.00
  • Revenue This Year
  • COEP N/A
  • FENG N/A
  • Revenue Next Year
  • COEP N/A
  • FENG N/A
  • P/E Ratio
  • COEP N/A
  • FENG N/A
  • Revenue Growth
  • COEP N/A
  • FENG 1.69
  • 52 Week Low
  • COEP $2.31
  • FENG $1.67
  • 52 Week High
  • COEP $13.70
  • FENG $4.15
  • Technical
  • Relative Strength Index (RSI)
  • COEP 45.50
  • FENG 47.35
  • Support Level
  • COEP $9.01
  • FENG $2.10
  • Resistance Level
  • COEP $9.75
  • FENG $2.33
  • Average True Range (ATR)
  • COEP 0.84
  • FENG 0.11
  • MACD
  • COEP -0.03
  • FENG -0.00
  • Stochastic Oscillator
  • COEP 46.07
  • FENG 50.11

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

Share on Social Networks: